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Control and Prevention, Penglai, ChinaAbstractAn emerging infectious disease, severe fever with thrombocytopenia syndrome (SFTS), was identiﬁed to be associated with a novel SFTS virus
(SFTSV). Transmission of the disease among humans has been described, but clinical impact factors and transmission mechanisms still need
further study. An outbreak of person-to-person transmission of SFTS in a cluster of nine patients that occurred in an SFTS endemic area,
Penglai County, Shandong province, China, was investigated. We found that the onset date of all eight secondary SFTS patients ranged
from 7 to 13 days after exposure to the corpse of the index patient, and clinical incubation time was mostly focused on 9–10 days
(n = 6). The two dead patients, including the index patient and one secondary infected patient, presented unusually high levels of viral
load (6 × 108-9 copies/mL), low levels of platelets count (<55 × 109/L), and signiﬁcant increase of alanine aminotransferase, aspartate
aminotransferase, lactate dehydrogenase, and creatine kinase values in the second week, and died on day 10 or 11 after disease onset.
Genetic sequencing revealed 100% homology among virus strains isolated from the index patient and ﬁve secondary patients. Risk factors
assessment of the person-to-person transmission revealed that the major exposure factor was blood contact without personal protection
equipment. Information from this study provided solid references of SFTS incubation time, clinical and laboratory parameters related to
SFTS severity and outcome, and biosafety issues for preventing person-to-person transmission or nosocomial infection of SFTSV.
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X.L. Jiang and S. Zhang contributed equally to this workIntroductionSevere fever with thrombocytopenia syndrome (SFTS) is an
emerging infectious disease caused by SFTS virus (SFTSV), a
newly identiﬁed pathogenic member of the Phlebovirus speciesMicrobiol Infect 2015; 21: 274–279
nical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infect
p://dx.doi.org/10.1016/j.cmi.2014.10.006in the family Bunyaviridae [1,2]. The major clinical signs and
symptoms of SFTS include high fever, gastrointestinal symp-
toms, thrombocytopenia, leukocytopenia, and multi-organ
dysfunction with an average case-fatality rate of 10–16%.
SFTS has been reported in at least 17 provinces in the central,
eastern, and northeastern regions of the People’s Republic of
China. Similar disease has also been reported in the United
States, South Korea, and Japan, showing the risk of disease
spread [3–6]. SFTS has become a severe threat to public health.
Ticks of the species Haemaphysalis longicornis were supposed
to be the vector of SFTSV infection to humans [1], as well as
sheep, cattle, and dogs, which, with relatively high infection
rates of SFTSV, may act as amplifying hosts for the virus duringious Diseases. Published by Elsevier Ltd. All rights reserved
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clear tick-bite or animal hosts-contact history before their
onset of the disease [8]. The infection cases of SFTSV
commonly showed a sporadic distribution, and clustered cases
occur less frequently [9]. Transmission of SFTS among humans
has been described [10–12], but clinical impact factors and
transmission mechanisms still need to be more studied.
From the end of August to the middle of September, there
was an outbreak of a cluster of nine suspected SFTS cases in
Penglai County, Shandong province, an endemic area of SFTS in
China, with two deaths, including the index patient and one
secondary patient. Here we report the results of the investi-
gation into this cluster of SFTS patients.MethodsPatients and sample collection
During August 25–September 17, 2013, a cluster of nine SFTS-
suspected patients was identiﬁed in Penglai County, Shandong
province. A 66-year old female farmer, who ﬁrst had onset of
illness on August 25, was admitted to a local village clinic, then
transferred to municipal hospital A on August 30, and hospital B
on September 2, and she died on September 4. The patient was
deﬁned as the index patient. The other eight cases in the cluster
were: Case 1, a 62-year old woman who was the sister-in-law
of the index patient; Case 2, the index patient’s 41-year-old
younger son; Cases 3 and 4, both village residents; Cases 5 and
6, the index patient’s brother and sister-in-law; Case 7, a 71-
year old female neighbour of the index patient; and Case 8,
the index patient’s husband. All eight of these patients had
onset of the disease from September 11 to September 17, and a
series of serum samples were collected from the diagnosis of
the disease and during the course of the illness.
Epidemiologic investigations
Besides the eight SFTS-suspected patients with similar clinical
presentations, all contacts of the index patient included 87 hos-
pital physicians and nurses; ﬁve patients who were staying in the
same sickroom with the index patient; and 26 persons from the
village who visited the room where the corpse was kept and
participated in the funeral of the index patient. All of these in-
dividuals were interviewed by telephone or in person with the
use of a standard questionnaire. The questionnaire requested the
following information: general information such as age, gender,
and profession; exposure to ticks and wild animals; contacts with
the index patient—e.g. when, where, and how they had contact;
exposure to the index patient’s skin, blood, and respiratory se-
cretions; whether they washed their hands after exposure.
Healthcare workers were asked about their use of personalClinical Microbiology and Infection © 2014 European Society of Clinical Microbiologyprotective equipment (PPE), such as mask, gloves, and gown.
Medical records of all nine SFTS patients were reviewed for the
time of onset and progression of the illness.
Laboratory analysis
Specimens from the nine clustered patients were subjected to
both nucleic acid and serological laboratory test. The viral RNAs
were tested by real-time reverse transcriptase polymerase chain
reaction as described previously [13], and the quantities of viral
RNA copies in the samples were calculated. Virus isolation, gene
sequencing, and speciﬁc IgM and IgG antibody detection by ELISA
were also performed as previously described [14].
Ethical review
According to the medical research regulation of the National
Health and Family Planning Commission of China, the investi-
gation was reviewed and approved by the ethics committee of
China CDC (Chinese Centers for Disease Control and Pre-
vention), which uses international guidelines to ensure conﬁ-
dentiality, anonymity, and informed consent. Informed consent
was obtained from all study participants.ResultsIndex patient
The index patient was a 66-year-old woman. On August 25,
2013, she presented to the local village clinic with fever (38.5°
C), abdominal pain, nausea, and vomiting without known
reason. She was treated with ribavirin and cephalothin at the
local village clinic. After 5 days, the symptoms were getting
worse and she was admitted to municipal hospital A on August
30 with diagnosis of “abdominal pain of unknown origin.”
Laboratory tests performed on admission revealed leukopenia
(white blood cells count 2.01 × 109/L), thrombocytopenia
(platelets count 96 × 109/L), elevated liver-associated enzyme
levels (aspartate aminotransferase (AST) 608U/L; alanine
aminotransferase (ALT) 322U/L; lactate dehydrogenase (LDH)
581U/L), and coagulopathy (activated partial thromboplastin
time (APTT) 46.7 seconds). No improvement was observed
after clinical treatment; her condition continued to decline. The
patient was transferred to municipal hospital B on September 2
and diagnosed as a suspected SFTS case. In the evening, her
condition deteriorated rapidly, with short breath and limb
tremor. She was then intubated and mechanically ventilated,
and received plasma and antiviral therapy. Laboratory values
indicated impaired liver and kidney function (white blood cells
25.04 × 109/L, platelets 54 × 109/L, AST 2010 U/L, ALT 892 U/
L, LDH 3608 U/L, APTT 95 seconds, creatine kinase (CK)
2061 U/L, CK-MB 180 U/L), and her symptoms furtherand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21 274–279
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In the early morning of September 4, the patient was taken
home with tracheal intubation and intravenous needles, and half
an hour after arriving home, she died. This was at day 10 after
the onset of disease, and the dead patient had history of a tick
bite 1 month before.
Epidemiologic ﬁndings
Seven to 13 days after the index patient’s death, eight persons
who had close exposure to the index patient presented typical
SFTS symptoms and were diagnosed as secondary patients.
Interviews were conducted with the eight secondary clustered
patients and a review of medical records reconstructed of the
timeline of relevant exposures and the onset of illness in the
cluster (Fig. 1, Table 1).
Case 1, the index patient’s sister-in-law, took care of the
dead body for 3 days and had to wipe off the blood from the
corpse. During the close exposures to the index patient, she
had no protection, and on September 11, she had disease onset
with a severe fever of 39.5°C and died on September 20.
Case 2, the younger son of the index patient, took care of his
mother when she was in the hospital and was involved in
removing the tracheal tube after his mother’s death. He had
unprotected contacts with the index patient. On September 13,
he became ill with high fever (38.5°C).
Case 3 and Case 4 were residents of the village where the
index patient lived. They participated in funeral matters and had
direct blood contact with the dead body. They both had onset
of the disease 7 days after exposure.
Case 5 and Case 6, the index patient’s brother and sister-in-
law, took care of the dead body. Case 5 participated in tracheal
tube removing and Case 6 changed the index patient’s clothes
after she died at home. They both had unprotected blood
contact with the index patient and developed fevers on
September 13 and 14, respectively.FIG. 1. Timeline of disease onset dates for a cluster of nine SFTS (severe fe
progression of critical symptoms during the index patient’s illness, and the ons
from 7 to 13 days after exposure to the dead body of the index patient, and
Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InfectCase 7 was a neighbour of the index patient who helped
transport the corpse and developed a fever of 39.1°C on day 8
after exposure.
Case 8, the index patient’s husband, took care of his wife
when she was in the hospital, was involved in withdrawing
intravenous needles, and participated in funeral matters. He had
disease onset on September 18.
Clinical characteristics
All nine patients in the cluster developed a fever ranging from
38.2°C to 39.5°C, and they also had general SFTS clinical features,
including gastrointestinal symptoms, thrombocytopenia, and
leukocytopenia. Two deaths, including the index patient andCase
1, both had skin silt ecchymosis, limb tremor, and respiratory
failure, and died of disseminated intravascular coagulation. As is
shown in Table 2, laboratory tests showed high levels of liver
enzymes (including ALT, AST), myocardial enzymes (including
LDH, CK), blood urea nitrogen, and creatinine in the ﬁrst week
after disease onset,whichmight indicate impaired liver, heart, and
kidney functions, respectively. In the surviving SFTS patients, the
serum tissue enzymes reached maximal values at days 9–11 and
declined thereafter, and the levels reverted to almost normal at
the end of the second week. The white blood cell and platelet
values also reverted to the normal range in survivors. An
important factor was that for the two dead patients, parameters
of ALT, AST, and LDH appeared to progressively rise and
reached unusually high levels, and they had signiﬁcantly elongated
APTT. Consistent with the largely reduced platelet count, the
index patient also showed a high level of CK value accompanied
with a quite low level of ﬁbrinogen, which represented a largely
impaired coagulation function.
Laboratory data
By real-time reverse transcriptase polymerase chain reaction
assay, the SFTSV viral RNA, including L, M, and S genever with thrombocytopenia syndrome) patients. Epidemic curve shows
et of SFTS in the eight clustered patients, of which the onset date ranged
clinical incubation time was mostly focused on 9–10 days (n = 6).
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21 274–279
TABLE 1. Epidemiologic features of a cluster of 9 patients with SFTS
Index Patient Case 1 Case 2 Case 3 Case 4 Case 5 Case 6 Case 7 Case 8
Sex Female Female Male Male Male Male Female Female Male
Age, years 66 62 42 58 60 71 61 71 71
Occupation Farmer Farmer Farmer Farmer Farmer Farmer Farmer Farmer Farmer
Tick-bite history Yes No No No No Yes No No No
Previous diseases Uterine myoma Healthy Healthy Healthy Healthy Healthy Type 2 diabetes Healthy Healthy
Date of onset Aug 25, 2013 Sep 11, 2013 Sep 13, 2013 Sep 13, 2013 Sep 13, 2013 Sep 13, 2013 Sep 14, 2013 Sep 14, 2013 Sep 17, 2013
Incubation time, days NA 7 9 9 9 9 10 10 13
Length after onset, days 11 10 21 18 15 17 18 27 20
Outcome Death Death Discharge Discharge Discharge Discharge Discharge Discharge Discharge
SFTS = severe fever with thrombocytopenia syndrome.
CMI Jiang et al. SFTS virus in Penglai, China 277fragments were detected in the sera collected from the index
patient and the other eight clustered patients. It is noticeable
that the sera collected from the two dead patients contained
relatively high levels of SFTS viral load, which reached about
6.04 × 109 copies/mL and 6.92 × 108 copies/mL, respectively.
These numbers were much higher than viral copies detected in
the other seven clustered patients’ sera, which ranged from 103
to 104 copies/mL (Table 2). The SFTS virus-speciﬁc IgM and IgG
antibodies in serum samples collected in the acute phase were
demonstrated by ELISA. Elevated IgM and IgG antibodies against
SFTSV showed in serum samples of all seven surviving patients.
The two patients who died, however, had minimal or unde-
tectable levels of virus-speciﬁc IgM antibodies.
We further isolated the SFTSV strains from the index patient
and ﬁve of the secondary patients. Phylogenetic trees based on
complete viral genomic sequences of L, M, and S segments
showed that the three SFTSV isolates were clustered together,
with 100% amino acid homology for all three segments, and alsoTABLE 2. Clinical symptoms and laboratory ﬁndings of a cluster of
Index Patient Case 1 Case 2 C
Clinical symptoms
Fever Yes Yes Yes Ye
Nausea Yes Yes Yes Ye
Vomiting Yes No Yes Ye
Myalgia Yes Yes Yes Ye
Haematuria Yes No No N
Skin silt ecchymosis Yes Yes No N
Tremors Yes Yes No N
Meningitis pathological character Yes Yes No N
Laboratory ﬁndings
PLT count ( × 109)a 96/54 54/31 82/169 13
WBC count ( × 109)a 2.01/25.04 1.5/4.18 2.25/3.87 1.
ALT (U/L)a 322/892 36/468 61/44 88
AST (U/L)a 608/2010 118/2607 65/38 95
LDH (U/L)a 581/3608 465/3506 193/180 25
CK (U/L)a 172/2061 176/391 81/37 61
Creatinine (U/L)a 53.3/40.7 69.0/199.0 70.2/54.9 75
APTT (s)a 46.7/95.0 54.1/85.5 38.3/32.1 34
Fibrinogen (g/L)a 1.72/0.59 2.19/1.56 2.43/2.06 1.
Proteinuria +++ NT +++ −
Haematuria ++ NT + −
Virus isolation Yes Yes No N
Viral RNA (copies/mL) 6.04 × 109 6.92 × 108 6.69 × 103 8.
IgM antibody − − + +
IgG antibody − − + +
−, negative; +, weak positive; +++, strong positive; ALT, alanine aminotransferase; APTT, activ
LDH, lactate dehydrogenase; NT, not tested; PLT, platelets; SFTS, severe fever with thromb
aThe two numbers represent laboratory value of samples collected in the ﬁrst and second w
Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiologyclosely related to other SFTSV strains. The high homology of
the viral isolates from the index patient and ﬁve affected pa-
tients provided genetic evidence for the epidemic ﬁndings on
the possible transmission of SFTS.
Risk factors of person-to-person transmission of SFTSV
To assess risk factors of this person-to-person transmission of
SFTSV, we collected information on all 126 individuals who had
exposure to the index patient from onset of the illness to
cremation of the corpse. As shown in Table 3, of the total 126
exposed individuals, 41, including 28 healthcare workers, eight
family members, and ﬁve villagers, reported direct blood con-
tact with the index patient by taking care of her before or after
her death; 11 of them got infected and eight developed the
disease (19.5%). Twenty-ﬁve individuals reported exposure to
the urine and faeces of the index patient, while only two
developed the disease (8.0%). Furthermore, the protective ef-
fect of PPE was evaluated. Of the total 126 contacts, 86 were9 patients with SFTS
ase 3 Case 4 Case 5 Case 6 Case 7 Case 8
s Yes Yes Yes Yes Yes
s Yes Yes Yes Yes Yes
s No No Yes Yes Yes
s Yes Yes Yes Yes Yes
o No No No No No
o No No No No No
o No No No No No
o No No No No No
9/237 83/194 50/262 54/263 178/34 55/168
98/5.98 1.29/4.36 1.73/4.74 2.81/4.65 1.83/4.15 2.60/6.30
/26 27/36 121/23 62/17 28/269 35/107
/16 33/38 283/19 101/17 33/289 37/45
6/240 189/267 473/223 275/203 185/1140 206/205
3/108 430/66 988/39 134/41 78/297 142/34
.0/60.2 70.4/53.6 84.3/63.6 55.2/48.0 59.0/47.7 66.6/52.3
.3/23.9 36.1/31.4 46.5/26.4 37.3/20.7 49.9/60.1 36.8/37.5
56/2.31 2.38/2.95 1.83/2.73 1.72/2.15 2.07/2.26 2.60/2.74
− +++ +++ +++ ++
− + + − −
o Yes Yes Yes No Yes
45 × 103 9.02 × 103 8.70 × 103 8.75 × 103 1.55 × 103 2.96 × 104
+ + + + +
+ + + + +
ated partial thromboplastin time; AST, aspartate aminotransferase; CK, creatine kinase;
ocytopenia syndrome; WBC, white blood cells.
eek after disease onset, respectively.
and Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21 274–279
TABLE 3. Risk factors assessment of person-to-person
transmission of SFTSV
Close contacts, n
Attack
rate, %
Relative risk
(95% CI)a pbOverall
Developed
secondary
case
Blood <0.001
Exposed 41 8 19.5
Unexposed 85 0 0
Urine and faeces 1.377
(0.261–7.269)
1.000
Exposed 25 2 8.0
Unexposed 101 6 5.9
PPE <0.001
Did not use 40 8 20.0
Use 86 0 0
PPE, personal protection equipment; SFTSV, severe fever with thrombocytopenia
syndrome virus.
aInﬁnite or not able to be calculated.
bContinuity correction χ2 tests.
278 Clinical Microbiology and Infection, Volume 21 Number 3, March 2015 CMIwith protective equipment. All eight secondary patients were
unprotected when exposed to the index patient. Continuity
correction χ2 tests showed that blood contact was the most
likely mode of transmission (p <0.001) and PPE could effectively
protect contacts from infection (p <0.001, Table 3).DiscussionHere, we presented a cluster of nine SFTS patients in China
under the SFTS surveillance program. The index patient was
diagnosed for SFTS 8 days after disease onset because fever and
gastrointestinal symptoms are generally the ﬁrst to appear, and
can be easily confused with haemorrhagic fever with renal
syndrome and human anaplasmosis, and may lead to misdiag-
nosis, and then affect the therapy and prognosis of the disease.
Thus, the clinical differential diagnosis of SFTS is of great
importance. We were more inclined to consider that the
unique disease status of the index patient and a lack of pre-
caution contributed to this sporadic person-to-person trans-
mission. Seven to 13 days after the index patient’s death, eight
persons who had close exposure to the index patient’s dead
body presented typical SFTS symptoms, and clinical incubation
time was mostly focused on 9–10 days.
It is notable that the clinical futures and laboratory tests
showed that the two dead patients presented unusually high
levels of ALT, AST, and LDH, and had signiﬁcantly elongated
APTT. The index patient also showed a largely reduced platelet
count and a high CK value, accompanied with a quite low level
of ﬁbrinogen, which indicated a largely impaired coagulation
function. The virus copies were also extremely high when they
died. But in the surviving SFTS patients, the serum tissue en-
zymes reached maximal values at day 9–11 and declinedClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectthereafter; the levels almost reverted to normal at the end of
the second week. Therefore, the second week was critical in
the course of the disease, and these disease-severity-related
parameters might be used as indicators to determine the
prognosis of SFTS.
After the index patient’s death, the tracheal tube was
removed and intravenous needles were withdrawn from the
corpse; there was still bleeding from the dead body, which
indicated a severe thrombocytopenia of the patient. Besides,
the genus Phlebovirus was reported to remain infectious for a
long time period of 40 days in wet conditions at room tem-
perature. Therefore, we postulated that the index patient
worked as a powerful source to spread virus to people having
close contact with her. We also noticed that SFTSV nucleic acid
testing in serum samples of three contacts were positive, but
they had no clinical symptoms, suggesting the possibility of
latent infection of SFTS virus [15].
A probable route for this person-to-person spread of SFTSV
was direct contact transmission. The eight secondary patients
who had unprotected close contact with the index patient’s
dead body surface or blood and other secretions successively
became ill, and one secondary patient died. After epidemio-
logical follow-up, no patients with SFTS were identiﬁed in those
who had been exposed to the patients but with protection. Risk
factors assessment of the person-to-person transmission
revealed that the major exposure factors were close contact, in
particular, contact with blood (p <0.001). The possible mech-
anisms for this direct transmission between persons may be
through open wounds, impaired skin, or through mucosa of the
conjunctive, oral, or nasal cavity. Among these eight secondary
patients, six had contact with the index patient only after death,
indicating that the SFTSV-infected blood of the dead patient, in
whom the level of virus copies was extremely high, may remain
infectious even after patient death. In addition, regarding the
healthcare workers, almost all that were exposed to the index
patient or secondary patients were wearing PPE and none got
infected. Risk factors assessment showed that PPE could
effectively protect contacts from infection (p <0.001).
The lessons of person-to-person transmission of SFTSV we
learned from this study provided solid references of SFTS in-
cubation time, clinical and laboratory parameters related to
SFTS severity and outcome, and biosafety issues for preventing
person-to-person transmission or nosocomial infection of
SFTSV.Transparency declarationThe authors declare that they have no conﬂicts of interest.ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21 274–279
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